1. Potencjalne możliwości wykorzystania berberyny w przeciwdziałaniu insulinooporności i w cukrzycy typu 2
    Michalina Mróz et al, 2021, Postępy Higieny i Medycyny Doświadczalnej CrossRef
  2. Metabolic Syndrome-Related Kidney Injury: A Review and Update
    Lirong Lin et al, 2022, Frontiers in Endocrinology CrossRef
  3. Berberine chloride suppresses non-small cell lung cancer by deregulating Sin3A/TOP2B pathway in vitro and in vivo
    Jian Chen et al, 2020, Cancer Chemotherapy and Pharmacology CrossRef
  4. Phytopharmacology and Clinical Updates of Berberis Species Against Diabetes and Other Metabolic Diseases
    Tarun Belwal et al, 2020, Frontiers in Pharmacology CrossRef
  5. Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota
    Ying Wang et al, 2021, Frontiers in Endocrinology CrossRef
  6. The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis
    Mohammad Zamani et al, 2022, Frontiers in Nutrition CrossRef
  7. The Effective Role of Natural Product Berberine in Modulating Oxidative Stress and Inflammation Related Atherosclerosis: Novel Insights Into the Gut-Heart Axis Evidenced by Genetic Sequencing Analysis
    Richard Y. Cao et al, 2021, Frontiers in Pharmacology CrossRef
  8. Association of higher plasma leptin levels with HOMA-IR index, high sensitivity C-reactive protein and glycolipid metabolism in patients with chronic schizophrenia: A multi-center cross-sectional study
    Zhiwei Liu et al, 2022, Frontiers in Psychiatry CrossRef
  9. The Effect of Natural Antioxidants in the Development of Metabolic Syndrome: Focus on Bergamot Polyphenolic Fraction
    Cristina Carresi et al, 2020, Nutrients CrossRef